Center for Substance Abuse Prevention; Notice of Meeting, 70860-70861 [05-23155]

Download as PDF 70860 Federal Register / Vol. 70, No. 225 / Wednesday, November 23, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Reproductive Health in Developing Countries P01 Review. Date: December 5, 2005. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue, NW., Washington, DC 20036. Contact Person: Carla T. Walls, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–435–6898, wallsc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: November 8, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23201 Filed 11–22–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. VerDate Aug<31>2005 17:33 Nov 22, 2005 Jkt 208001 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Eukaryotic Pathogens and Vectors. Date: November 21, 2005. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Crystal City Marriott, 1999 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Fouad A. El-Zaatari, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, MSC 7808, Bethesda, MD 20814–9692. (301) 435–1149. elzaataf@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Bioengineering Technology and Surgical Sciences. Date: November 21, 2005. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Roberto J. Matus, MD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 20892. (301) 435– 2204. matusr@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Metalloprotein Structure. Date: November 21, 2005. Time: 4 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC 20037. Contact Person: George W. Chacko, PhD, Scientific Review Administrator, Center For Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4186, MSC 7849, Bethesda, MD 20892. (301) 435– 1220. chackoge@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 8, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23202 Filed 11–22–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Pub. L. 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health Services Administration (SAMHSA) Drug Testing Advisory Board on December 13–14, 2005. A portion of the meeting will be open and will include a roll call, general announcements, a Department of Health and Human Services drug testing program update, a Department of Transportation drug testing program update, and a Nuclear Regulatory Commission drug testing program update. Attendance by the public will be limited to space available. Public comments are welcome. Please communicate with the individual listed below as contact to make arrangements to comment or to request special accommodations for persons with disabilities. The Board will also meet to develop the final revisions to the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs that were published in the Federal Register on April 13, 2004 (69 FR 19673) and to discuss Federal agency specimen results, medical review officer interpretations, laboratory inspection issues, and analytical instrumentation issues. This meeting will be conducted in closed session since discussing these issues in open session will significantly frustrate the Department’s ability to develop the revisions to the Mandatory Guidelines or to disclose information of a personal nature where disclosure would constitute an unwarranted invasion of personal privacy. The HHS Office of General Counsel made the determination that such matters are protected by exemptions (6) and 9(B) of section 552b(c) of title 5 U.S.C. and therefore may be closed to the public. To facilitate entering the building for the open session, public attendees are E:\FR\FM\23NON1.SGM 23NON1 Federal Register / Vol. 70, No. 225 / Wednesday, November 23, 2005 / Notices required to contact Mrs. Giselle Hersh, Division of Workplace Programs, 1 Choke Cherry Road, Room 2–1042, Rockville, MD 20857, 240–276–2605 (telephone) or by e-mail to Giselle.Hersh@samhsa.hhs.gov. Substantive program information and a roster of Board members may be obtained by accessing the SAMHSA workplace Web site (http:// workplace.samhsa.gov) or communicating with the contact whose name and telephone number are listed below. The transcript for the open session will be available on the SAMHSA workplace Web site as soon as possible after the meeting. Committee Name: Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board. Meeting Date: December 13–14, 2005. Place: SAMHSA Building, Sugarloaf Conference Room, 1 Choke Cherry Road, Rockville, Maryland 20850. Type: Open: December 13, 2005; 8:30 a.m.–10:30 a.m. Closed: December 13, 2005; 10:30 a.m.–4:30 p.m. Closed: December 14, 2005; 8:30 a.m.– Noon. Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry Road, Room 2–1033, Rockville, Maryland 20857, 240–276–2600 (telephone) and 240–276–2610 (fax), email: Donna.Bush@samhsa.hhs.gov. Dated: November 17, 2005. Robert E. Stephenson, Acting Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. 05–23155 Filed 11–22–05; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2005–23024] International Code for the Construction & Equipment of Ships Carrying Dangerous Chemicals in Bulk— December 2005 Deadline for Manufacturers of Affected Products Coast Guard, DHS. Notice. AGENCY: ACTION: SUMMARY: The Coast Guard notifies manufacturers that there is a December 31, 2005 deadline to supply missing safety or pollution data for the revised International Code for the Construction & Equipment of Ships Carrying Dangerous Chemicals in Bulk, which VerDate Aug<31>2005 17:33 Nov 22, 2005 Jkt 208001 will affect the bulk shipment of certain products on most international voyages. DATES: The International Maritime Organization should receive missing data no later than December 31, 2005. ADDRESSES: Missing data can be delivered to the following address: GESAMP/EHS, International Maritime Organization, 4 Albert Embankment, London SE1 7SR, United Kingdom. You may submit comments identified by Coast Guard docket number USCG– 2005–23024 to the Docket Management Facility at the U.S. Department of Transportation. To avoid duplication, please use only one of the following methods: (1) Web Site: http://dms.dot.gov. (2) Mail: Docket Management Facility, U.S. Department of Transportation, 400 Seventh Street, SW., Washington, DC 20590–0001. (3) Fax: 202–493–2251. (4) Delivery: Room PL–401 on the Plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The telephone number is 202–366– 9329. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice, call Mr. Tom Felleisen, Hazardous Materials Standards Division (G–MSO–3), Coast Guard, telephone 202–267–0086. If you have questions on viewing or submitting material to the docket, call Renee V. Wright, Program Manager, Docket Operations, telephone 202–493–0402. SUPPLEMENTARY INFORMATION: Request for Comments All comments received will be posted, without change, to http://dms.dot.gov and will include any personal information you have provided. We have an agreement with the Department of Transportation (DOT) to use the Docket Management Facility. Please see DOT’s ‘‘Privacy Act’’ paragraph below. Submitting comments: If you submit a comment, please include your name and address, identify the docket number for this notice (USCG–2005–23024) and give the reason for each comment. You may submit your comments by electronic means, mail, fax, or delivery to the Docket Management Facility at the address under ADDRESSES; but please submit your comments by only one means. If you submit them by mail or delivery, submit them in an unbound format, no larger than 81⁄2 by 11 inches, suitable for copying and electronic filing. If you submit them by mail and would like to know that they reached the Facility, please enclose a stamped, self-addressed postcard or envelope. We PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 70861 will consider all comments received during the comment period. Viewing comments and documents: To view comments, go to http:// dms.dot.gov at any time, click on ‘‘Simple Search,’’ enter the last five digits of the docket number for this rulemaking, and click on ‘‘Search.’’ You may also visit the Docket Management Facility in room PL–401 on the Plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. Privacy Act: Anyone can search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or signing the comment, if submitted on behalf of an association, business, labor union, etc.). You may review the Department of Transportation’s Privacy Act Statement in the Federal Register published on April 11, 2000 (65 FR 19477), or you may visit http://dms.dot.gov. Background and Purpose The International Maritime Organization’s (IMO) Maritime Safety Committee adopted the revised International Code for the Construction & Equipment of Ships Carrying Dangerous Chemicals in Bulk (IBC Code) last year. Over 120 products were omitted from either Chapter 17 or 18 of the IBC Code due to missing safety and or pollution data. The 41st session of the Joint Group of Experts on the Scientific Aspects of Marine Environmental Protection working group on the Evaluation of the Hazards of Harmful Substances Carried by Ships and the most recent session of the working group on the Evaluation of Safety and Pollution Hazards updated this list. IMO will exclude these products from the revised IBC Code unless it receives the missing data by December 31, 2005. If these products are excluded, shippers will be unable to carry them in bulk after January 1, 2007 on most international voyages. Therefore, the manufacturers of these products should supply the missing safety and or pollution data to the IMO GESAMP/EHS Secretariat (see ADDRESSES) by December 31, 2005. This notice of an IMO action does not mean that the Coast Guard will necessarily be implementing the IMO action on all international shipments. Implementation of IMO actions would be the subject of a future rulemaking under a distinct docket. The affected products are: 1. Acetochlor 2. Alkaryl polyethers (C9–C20) 3. Alkenyl (C11+) amide E:\FR\FM\23NON1.SGM 23NON1

Agencies

[Federal Register Volume 70, Number 225 (Wednesday, November 23, 2005)]
[Notices]
[Pages 70860-70861]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-23155]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the Substance Abuse and Mental Health Services Administration 
(SAMHSA) Drug Testing Advisory Board on December 13-14, 2005.
    A portion of the meeting will be open and will include a roll call, 
general announcements, a Department of Health and Human Services drug 
testing program update, a Department of Transportation drug testing 
program update, and a Nuclear Regulatory Commission drug testing 
program update.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed 
below as contact to make arrangements to comment or to request special 
accommodations for persons with disabilities.
    The Board will also meet to develop the final revisions to the 
proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs that were published in the Federal Register on April 13, 2004 
(69 FR 19673) and to discuss Federal agency specimen results, medical 
review officer interpretations, laboratory inspection issues, and 
analytical instrumentation issues. This meeting will be conducted in 
closed session since discussing these issues in open session will 
significantly frustrate the Department's ability to develop the 
revisions to the Mandatory Guidelines or to disclose information of a 
personal nature where disclosure would constitute an unwarranted 
invasion of personal privacy. The HHS Office of General Counsel made 
the determination that such matters are protected by exemptions (6) and 
9(B) of section 552b(c) of title 5 U.S.C. and therefore may be closed 
to the public.
    To facilitate entering the building for the open session, public 
attendees are

[[Page 70861]]

required to contact Mrs. Giselle Hersh, Division of Workplace Programs, 
1 Choke Cherry Road, Room 2-1042, Rockville, MD 20857, 240-276-2605 
(telephone) or by e-mail to Giselle.Hersh@samhsa.hhs.gov.
    Substantive program information and a roster of Board members may 
be obtained by accessing the SAMHSA workplace Web site (http://
workplace.samhsa.gov) or communicating with the contact whose name and 
telephone number are listed below. The transcript for the open session 
will be available on the SAMHSA workplace Web site as soon as possible 
after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: December 13-14, 2005.
    Place: SAMHSA Building, Sugarloaf Conference Room, 1 Choke Cherry 
Road, Rockville, Maryland 20850.
    Type: Open: December 13, 2005; 8:30 a.m.-10:30 a.m.
    Closed: December 13, 2005; 10:30 a.m.-4:30 p.m.
    Closed: December 14, 2005; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry 
Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 (telephone) 
and 240-276-2610 (fax), e-mail: Donna.Bush@samhsa.hhs.gov.

    Dated: November 17, 2005.
Robert E. Stephenson,
Acting Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 05-23155 Filed 11-22-05; 8:45 am]
BILLING CODE 4162-20-P